November 26, 2024
Rose Gerber was 39, mother to a third grader and a kindergartener, when the diagnosis came: Advanced HER2-positive breast cancer. “On one of my first or […]
November 25, 2024
Blockbuster weight loss and type 2 diabetes drugs, such as Ozempic, carry a growing list of benefits. These drugs — known as glucagon-like peptide 1 (GLP-1) […]
November 22, 2024
TOPLINE: Death rates for patients aged < 50 years with early-onset colorectal cancer (EOCRC) are higher in native Hawaiian and Other Pacific Islander individuals and non-Hispanic […]
November 22, 2024
TOPLINE: Women exposed to drinking water contaminated with high levels of synthetic chemicals known as perfluoroalkyl substances (PFAS) are not at an elevated risk for hormone […]
November 22, 2024
The role of adjuvant immunotherapy in triple-negative breast cancer (TNBC) remains uncertain. Standard therapy for TNBC includes neoadjuvant pembrolizumab with chemotherapy followed by pembrolizumab, with or […]
November 21, 2024
The U.S. Food and Drug Administration (FDA) has approved zanidatamab (Ziihera, Jazz Pharmaceuticals, Inc.) as monotherapy for previously treated, unresectable or metastatic HER2-positive biliary tract cancer […]
November 21, 2024
TOPLINE: The Profile for the Omission of Local Adjuvant Radiation (POLAR) biomarker, a 16-gene molecular signature, can help predict locoregional recurrence in patients with ER-positive early […]
November 21, 2024
The national survival rate for lung cancer has increased by 26% in the past 5 years, to 28.4% of all cases, according to a new report […]
November 20, 2024
Clear cell renal cell carcinoma (RCC) comprises 80% of all primary kidney malignancies and causes 90% of kidney cancer deaths. But it is notoriously tough to […]